SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001144204-16-140964
Filing Date
2016-12-22
Accepted
2016-12-22 16:04:22
Documents
1
Group Members
DR. ANAND MEHRADR. JAMES I. HEALYDR. MICHAEL F. POWELLSOFINNOVA MANAGEMENT VIII, L.L.C.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A v455641_sc13d-a.htm SC 13D/A 116911
  Complete submission text file 0001144204-16-140964.txt   118599
Mailing Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025
Business Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025 650-681-8420
Sofinnova Venture Partners VIII, L.P. (Filed by) CIK: 0001524064 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 888-772-7560
Spark Therapeutics, Inc. (Subject) CIK: 0001609351 (see all company filings)

IRS No.: 462654405 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88577 | Film No.: 162066621
SIC: 2836 Biological Products, (No Diagnostic Substances)